The cell signaling market is projected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8 percent, estimates MarketsandMarkets. Growth in the medical supplies market is primarily driven by rising incidence of chronic diseases, and availability of funding for cell-based research activities. Other factors that are also positively affecting the growth of this market are technological advancements in cell-based research instruments and growth in life science and biopharmaceutical industries. However, ethical issues related to embryonic stem cell signaling research and the high cost of cell signaling systems are expected to hinder the growth of this market.

The endocrine signaling segment is estimated to account for the largest share of cell signaling market in 2017. In 2017, the consumables segment is estimated to account for the largest share of the cell signaling market. The microscopy segment is estimated to account for the largest share of cell signaling market in 2017. The research applications segment is estimated to account for the largest share of cell signaling market in 2017.

In 2017, the medical supplies market is dominated by North America, followed by Europe. North America is expected to continue to dominate the market by 2022. Asia is projected to witness the highest CAGR, centered at China, Japan, and India, over the next 5 years.


 

randox

Digital version